XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 5,989,000 $ 19,439,000
Short-term investments 12,886,000 0
Prepaid expenses and other current assets 309,000 389,000
Total current assets 19,184,000 19,828,000
Other assets 4,000 8,000
Total assets 19,188,000 19,836,000
Current liabilities:    
Accounts payable, accrued expenses and other 441,000 589,000
Total current liabilities 441,000 589,000
Total liabilities 441,000 589,000
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.01 par value: 10,000 shares authorized at December 31, 2023 and 2022 no shares issued or outstanding at December 31, 2023 or 2022
Common stock, $0.01 par value: 30,000 shares authorized at December 31, 2023 and 2022; 14,351 and 14,215 shares issued and outstanding at December 31,2023 and 2022 1,343,000 1,342,000
Additional paid-in capital 566,221,000 565,541,000
Accumulated deficit (548,817,000) (547,636,000)
Total stockholders’ equity 18,747,000 19,247,000
Total liabilities and stockholders’ equity $ 19,188,000 $ 19,836,000